Skip to content

Clinical trials

Phase 1 Small Cell Lung Carcinoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1 Country / region: Italy Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20192
20201
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated3
Active, not recruiting2
Recruiting2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Aileron Therapeutics, Inc.1
Amgen1
Celgene1
EMD Serono Research & Development Institute, Inc.1
Pfizer1
SystImmune Inc.1
Thena Biotech S.r.l.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma8
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2
Esophageal Neoplasms2
Stomach Neoplasms2
Triple Negative Breast Neoplasms2
Uterine Cervical Neoplasms2
Carcinoma, Hepatocellular1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.